PO.TB09.03 · 肿瘤生物学
Methods to Measure Tumor Evolution and Heterogeneity
-
-
-
-
-
- 690 690 Hierarchical mixed effects cubic spline modeling of methylation-based tumor fraction dynamics for pan-cancer assessment of treatment response and outcomes in immunotherapy patients Christopher Pretz, Amar Das, Carin Espenschied, Sara Wienke, Samantha I. Liang, Christopher Cabanski
- 691 691 Visualizing differential prostate cancer lesion growth in longitudinal MRIs of patients on active surveillance: Quantitative mapping by Habitat Risk Score and digital pathology Sandra M. Gaston, Yuwei Zhang, Veronica M. Wallaengen, Amanda Galvez, Leonard Salcedo, Adrian L. Breto, Ahmad Algohary, Noah C. Lowry, Jakub Karczmarzyk, Gupta R. Rajarsi, Erich Bremer, Tahsin Kurc, Benjamin O. Spieler, Oleksandr N. Kryvenko, Alan Pollack, Sanoj Punnen, Joel Saltz, Radka Stoyanova
- 692 692 Novel single cell and bulk NGS assays for improved assessment of MRD (measurable residual disease) and clonal dynamics in acute myeloid leukemia (AML) Crystal Zhou, Ruwan Gunaratne, Emily Yang, Rachel Agoglia, Diwash Jangam, Charu Tiwari, Kailee Tanaka, Tsoyu Chiang, Chandler Ho, Sydney Lu, James L. Zehnder, Bing Melody Zhang, Henning Stehr, Tian Yi Zhang
-
-
-
-
-
- 699 699 Dynamic adaptation and heterogeneity in tumor patient-derived organoids: Insights into cancer evolution and drug resistance Javier Frias Aldeguer, Jasmin Pourfarzad, Alessandro Gregory, Farzin Pourfarzad, Rene Overmeer, Robert G. J. Vries, Sylvia F. Boj
-
- 701 701 Patient-derived organoid biobanks preserve tumor heterogeneity and molecular signatures Rene Overmeer, Farzin Pourfarzad, Alejandra Hernandez Segura, Merel Derksen, Carla Verissimo, Robert G. J. Vries, Sylvia F. Boj
-
-
-
-
-
